Avery Dennison has introduced a line of new syringe labeling products to its pharmaceutical portfolio. The portfolio extension features safe, compliant labelstock solutions, which are designed to meet manufacturers’ standards for syringe and tight mandrel pharmaceutical applications. The new Avery Dennison syringe portfolio includes products that offer low migration and high-performance adhesives on flexible paper and film facestocks. The products are sterilization-friendly and resistant to heat, steam and chemicals. Photoluminescent options are available to aid with missing label detection using ultraviolet light. Adhesives used within the pharmaceutical industry must undergo comprehensive FDA testing to ensure they comply with toxicology requirements. If any adhesive changes are to occur, Avery Dennison notifies converters months in advance in order to make sure the new formulations are properly tested for compliance.
Mentor, OH, USA